|
Volumn 24, Issue 4, 2001, Pages 323-333
|
Melanoma-reactive CD8+ T cells recognize a novel tumor antigen expressed in a wide variety of tumor types
a a a a a a |
Author keywords
Human; Melanoma; T lymphocytes; Tumor immunity
|
Indexed keywords
CD8 ANTIGEN;
COMPLEMENTARY DNA;
EPITOPE;
GENE PRODUCT;
HLA ANTIGEN CLASS 1;
MESSENGER RNA;
PROTEIN AIM 2;
TUMOR ANTIGEN;
TUMOR VACCINE;
UNCLASSIFIED DRUG;
ALLELE;
ANTIGEN EXPRESSION;
ARTICLE;
COLON CARCINOMA;
CONTROLLED STUDY;
DNA LIBRARY;
DRUG TARGETING;
GENE EXPRESSION;
GENE SEQUENCE;
GENETIC CODE;
GENETIC PROCEDURES;
GENETIC TRANSCRIPTION;
HUMAN;
HUMAN CELL;
MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION;
MELANOMA;
MELANOMA CELL;
MOLECULAR CLONING;
NUCLEOTIDE SEQUENCE;
OPEN READING FRAME;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN MOTIF;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
T LYMPHOCYTE;
TUMOR CELL CULTURE;
TUMOR IMMUNITY;
AMINO ACID SEQUENCE;
ANTIGENS, NEOPLASM;
BASE SEQUENCE;
CD8-POSITIVE T-LYMPHOCYTES;
CELLS, CULTURED;
EPITOPES;
GENE EXPRESSION;
HLA-A1 ANTIGEN;
HUMANS;
INTERFERON TYPE II;
LYMPHOCYTE CULTURE TEST, MIXED;
MELANOMA;
MOLECULAR SEQUENCE DATA;
NUCLEAR PROTEINS;
TUMOR CELLS, CULTURED;
|
EID: 0034839946
PISSN: 10538550
EISSN: None
Source Type: Journal
DOI: 10.1097/00002371-200107000-00008 Document Type: Article |
Times cited : (30)
|
References (24)
|